The Motley Fool

Key Data Points

Primary metrics and data points about Amicus Therapeutics, Inc..
Current Price: $15.79
Prev Close: $15.74
Open: $15.81
Bid: $15.80
Ask: $15.84
Day's Range: $14.80 - $16.00
52wk Range: $3.92 - $17.42
Volume: 2,038,589
Avg Vol 2,785,532
Market Cap: $2B
P/E (ttm): -16.92
EPS (ttm): ($0.93)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Amicus Therapeutics, Inc..

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

FOLD vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Amicus Therapeutics, Inc..
CAPS Rating 3 out of 5
 
108 Outperform
28 Underperform
CAPS All Stars
 
31 Outperform
9 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John F. Crowley, CEO

100% Approve

Based on 7 Ratings

Powered by

More Details about Amicus Therapeutics, Inc.

Primary metrics and data points about Amicus Therapeutics, Inc..